- Quote, Chart, News
- Snapshot
- Company Report
- Quotes
- Charts
- Key Developments
Recent News- Research
- SEC Filings
- Advisor FYI
- CAPS
- StockScouter
- Earnings Estimates
- Analyst Ratings
- Financial Results
- Insider Trading
- Ownership
- Message Board
- Guided Research
- Research Wizard
- Find Stocks
- Stock Screener
- Stock Power Searches
- Top-Rated Stocks
- Related Links
- Quote Watchlist
- Expert Picks
- E-mail & Alerts
- IPO Center
- Message Boards
- Capital Gains Analysis
News resources
| Incyte Corp (INCY) | 2 stories... |
| American International Group Inc (AIG) | 2 stories... |
| LM Ericsson Telephone ADR Reptg 1 Ord Shs Class B (ERIC) | 2 stories... |
| New York Times Co (NYT) | 1 story... |
| Ford Motor Co (F) | 1 story... |
| advertisement |
Glaxosmithkline ADR rep 2 ord shs: All Recent News
- Batch of swine flu vaccines studied in Canada 11/24/2009
- LONDON (AP) - Canadian doctors have been advised not to use a batch of 170,000 doses of swine flu vaccine while authorities investigate reports of allergic reactions among recipients, drug maker GlaxoSmithKline PLC said Tuesday. Associated Press
- Gilead signs sales deal with Glaxo for Viread 11/24/2009
- NEW YORK (AP) - Gilead Sciences Inc. and GlaxoSmithKline said Tuesday they signed a deal to sell Viread as a hepatitis B treatment in Asia. Associated Press
- Cel-Sci's History of Disappearing Drugs: BioBuzz 11/24/2009
- Will the company's flu drug last longer than its other fly-by-night projects? At TheStreet.com
- Gilead and GlaxoSmithKline Announce Agreement to Commercialize... 11/24/2009
- Gilead Sciences, Inc. (Nasdaq:GILD) and GlaxoSmithKline (NYSE:GSK) today announced a licensing agreement to commercialize Viread® (tenofovir disoproxil fumarate) for the treatment of chronic... Business Wire
- BioCryst Bull Blames Conspiracy for Stock's Fall: BioBuzz 11/24/2009
- Hedge funds, Wall Street, SEC and FDA out to hurt maker of flu drug, newsletter writer claims. At TheStreet.com
- $ Valeant Shares Fall Ill 11/23/2009
- ... At Barron's
- GlaxoSmithKline pulls application for new drug use 11/23/2009
- TRENTON, N.J. (AP) - British drugmaker GlaxoSmithKline PLC said Monday it is temporarily withdrawing its application for U.S. approval of a drug to prevent prostate cancer. Associated Press
- Healthcare Stocks: Safe and Speculative 11/23/2009
- NEW YORK (TheStreet) -- Allos Therapeutics is the best speculative bet in the sector. Watch this video for the safest and biggest growth stock to add to your portfolio. At TheStreet.com
- Canada stops use of one batch of flu vaccine 11/23/2009
- ... At Thomson Reuters
- Barron's Magazine First Read: Dividends, VRX, DISCA 11/23/2009
- ... At Barron's
- UPDATE 1-Glaxo temporarily withdraws Avodart cancer filing 11/23/2009
- ... At Thomson Reuters
- $ Hot Drug Stock in Need of a Chill Pill 11/21/2009
- ... At Barron's
- Canada to have vaccine soon for half population 11/20/2009
- ... At Thomson Reuters
- Pfizer's Generics Business Takes Shape 11/20/2009
- ... At Wall Street Journal
- UPDATE 1-EU body backs single dose for 2 H1N1 flu vaccines 11/20/2009
- ... At Thomson Reuters
- More News
- Market Report
- News by Symbol
- Today's Investing Articles
- Breaking News
- News by Topic
- News by Industry
- MSNBC News
- Data providers
- Copyright © 2009 Thomson Reuters. Click for Restrictions.
- Quotes supplied by Interactive Data Real-Time Services.